Oppilotech have developed a unique high-resolution platform based on systems biology and machine learning to model biological processes in cells. The platform is utilized to identify first-in-class viable drug targets and to develop novel modes of action drugs modulating the identified targets. Three first-in-class antibacterial drug targets and generated active chemical matter against 2 of them.
|Category||AI & Biotech|
|Partner||Innovate UK Babraham Accelrator Francis Crick Institute|
|Investment Portfolio||Pre-Fund Investment|